Le Gall J R, Lemeshow S, Leleu G, Klar J, Huillard J, Rué M, Teres D, Artigas A
Faculty of Medicine, Lariboisière-Saint Louis, Paris, France.
JAMA. 1995 Feb 22;273(8):644-50.
To develop customized versions of the Simplified Acute Physiology Score II (SAPS II) and the 24-hour Mortality Probability Model II (MPM II) to estimate the probability of mortality for intensive care unit patients with early severe sepsis.
Logistic regression models developed for patients with severe sepsis in a database of adult medical and surgical intensive care units in 12 countries.
Of 11,458 patients in the intensive care unit for at least 24 hours, 1130 had severe sepsis based on criteria of the American College of Chest Physicians and the Society of Critical Care Medicine (systemic inflammatory response syndrome in response to infection, plus hypotension, hypoperfusion, or multiple organ dysfunction).
In patients with severe sepsis, mortality was higher (48.0% vs 19.6% among other patients) and 28-day survival was lower. The customized SAPS II was well calibrated (P = .92 for the goodness-of-fit test) and discriminated well (area under the receiver operating characteristic [ROC] curve, 0.78). Performance in the validation sample was equally good (P = .85 for the goodness-of-fit test; area under the ROC curve, 0.79). The customized MPM II was well calibrated (P = .92 for the goodness-of-fit test) and discriminated well (area under the ROC curve, 0.79). Performance in the validation sample was equally good (P = .52 for the goodness-of-fit test; area under the ROC curve, 0.75). The models are independent of each other; either can be used alone to estimate the probability of mortality of patients with severe sepsis.
Customization provides a simple technique to apply existing models to a subgroup of patients. Accurately assessing the probability of hospital mortality is a useful adjunct for clinical trials.
开发简化急性生理学评分II(SAPS II)和24小时死亡概率模型II(MPM II)的定制版本,以估计早期严重脓毒症重症监护病房患者的死亡概率。
在12个国家的成人内科和外科重症监护病房数据库中,为严重脓毒症患者开发逻辑回归模型。
在重症监护病房至少24小时的11458例患者中,根据美国胸科医师学会和危重病医学会的标准(对感染的全身炎症反应综合征,加上低血压、低灌注或多器官功能障碍),有1130例患有严重脓毒症。
严重脓毒症患者的死亡率更高(48.0%,而其他患者为19.6%),28天生存率更低。定制的SAPS II校准良好(拟合优度检验P = 0.92),区分能力良好(受试者操作特征[ROC]曲线下面积为0.78)。验证样本中的表现同样良好(拟合优度检验P = 0.85;ROC曲线下面积为0.79)。定制的MPM II校准良好(拟合优度检验P = 0.92),区分能力良好(ROC曲线下面积为0.79)。验证样本中的表现同样良好(拟合优度检验P = 0.52;ROC曲线下面积为0.75)。这些模型相互独立;任何一个都可以单独用于估计严重脓毒症患者的死亡概率。
定制提供了一种将现有模型应用于患者亚组的简单技术。准确评估医院死亡率的概率是临床试验的有用辅助手段。